An outbreak of measles in Iraq
| dc.contributor.author | Al-Ani, Raid | |
| dc.contributor.author | Abdul-Rasool, Sahar | |
| dc.date.accessioned | 2025-10-29T11:14:21Z | |
| dc.date.available | 2025-10-29T11:14:21Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Measles is a highly contagious illness which can be prevented by a vaccine. It needs to be interrupted from transmission through population based immunity. The causative agent (measles virus) is a negative strand ribonucleic acid (RNA) virus. Measles is considered a serious public health problem because its causative virus is transmitted through droplets or aerosols, can induce systemic infection, and suppress the immune response even following a long period of getting the infection. The standard vaccination of children against measles is through attaining a two-dose immunization schedule, as a single dose can only provide 15% immunity. It is necessary to reach and maintain 95% of the population immunization against measles. Despite the presence of an effective and safe attenuated live virus vaccine, measles is still considered a dangerous disease worldwide resulting in the death of 136,000 (mostly children) in the year 2022. Measles outbreaks are suspected and should be declared when the number of cases reported in a region exceeds the usual number of cases. The increment rate of reported measles cases and deaths from this illness in 2022 is 18% and 43% respectively, in comparison with the year 2021 across the globe. | |
| dc.identifier.citation | Al-Ani, R.M. and Abdul-Rasool, S., 2024. An Outbreak of Measles in Iraq. | |
| dc.identifier.uri | https://doi.org/10.33091/amj.2024.147424.1610 | |
| dc.identifier.uri | https://hdl.handle.net/10566/21320 | |
| dc.language.iso | en | |
| dc.publisher | University of Anbar | |
| dc.subject | Iraq | |
| dc.subject | Measles | |
| dc.subject | Outbreak | |
| dc.subject | Immunization | |
| dc.subject | COVID-19 pandemic | |
| dc.title | An outbreak of measles in Iraq | |
| dc.type | Article |